pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Cell Therapy · news · pharmadog
← back to Cell Therapy
News · Cell Therapy
309
stories
Oct 6, 26
AstraZeneca hopes to ‘achieve amazing things’ with new Kendall Square R&D center
fiercebiotech
Oct 6, 26
BioSpace 40 Under 40 winners make their mark on biopharma
biospace
Oct 5, 26
Significant stock movers of September: Viking soars, Longeveron slides
biospace
Oct 5, 26
Trio of scientists who developed neuron light switches win Nobel Prize in Physiology or Medicine
fiercebiotech
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Oct 5, 26
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
biospace
Oct 1, 26
Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEO
fiercebiotech
Sep 30, 26
Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips again
biospace
Sep 30, 26
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
biopharma dive
Sep 30, 26
BioNTech to close German manufacturing plants after failing to find buyers
biospace
Sep 30, 26
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
Sep 29, 26
Spark co-founder Steven Altschuler is back with an immune-resetting biotech
endpoints
Sep 28, 26
Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway
endpoints
Sep 28, 26
ai3Bio emerging from stealth to ‘take the gun out of the hands of the immune system’
fiercebiotech
Sep 28, 26
An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus
biopharma dive
Sep 28, 26
STAT+: It really is bleak out there, and list prices matter
stat
Sep 28, 26
STAT+: AbbVie wins FDA nod for Parkinson’s pill
stat
Sep 28, 26
STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’
stat
Sep 28, 26
Regenerative medicine needs more than stem cells
biospace
Sep 25, 26
STAT+: Lilly wins approval for once-weekly insulin shot
stat
Sep 25, 26
Endpoints 11 2026 winner Azalea melds gene editing and CAR-T
endpoints
Sep 25, 26
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
fiercebiotech
Sep 24, 26
STAT+: FDA commissioner nominee Heidi Overton keeps opinions to herself in Senate hearing
stat
Sep 24, 26
The FDA’s Overton era, and dispatches from Shanghai
stat
Sep 24, 26
US senators grill FDA nominee Overton on ability to ‘stand up’ to Trump
biospace
Sep 24, 26
STAT+: Kyverna’s cell therapy shows lasting autoimmune benefit
stat
Sep 24, 26
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
Sep 23, 26
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
Sep 21, 26
Mikhail, Davis on board with regulatory framework tailored to rare disease therapies
biospace
← prev
page 4 of 11
next →